Drug intelligence / Profile preview

aimiduoer hydrochloride

Development stage
Unknown
Lead developer
Shenyang Pharmaceutical University
Modality
Small Molecules
Administration
Oral
01

Overview

Aimiduoer hydrochloride is a novel small molecule antiviral agent developed for the treatment of chronic hepatitis B virus (HBV) infection. Originally designed by researchers at Shenyang Pharmaceutical University, it is a structural derivative of the broad-spectrum antiviral drug umifenovir (Arbidol). Aimiduoer functions as an HBV capsid assembly modulator (CAM), specifically targeting the HBV core protein (HBcAg). By binding to the core protein, it interferes with the proper assembly of the viral nucleocapsid, which is essential for the encapsidation of pregenomic RNA and subsequent viral DNA synthesis. This disruption effectively inhibits the replication of HBV and the production of infectious virions. The drug has been advanced into clinical trials in China in collaboration with Guangzhou Boji Pharmaceutical.

Other names
AimiduoerAimiduo'er盐酸艾米朵尔
02

Targets

HBc (Hepatitis B virus core protein)

Beyond the preview

Go deeper on aimiduoer hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aimiduoer hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call